HEROIC Prostate Cancer Precision Health

• Research type

  Research Study

• Full title

  HEROIC Prostate Cancer Precision Health (PCaPH) Africa1K: Powering Precision Health to improve Prostate Cancer Outcomes in Africa

• IRAS ID

  357847

• Contact name

  Paul Jackson

• Contact email

  paul.r.jackson@uea.ac.uk

• Sponsor organisation

  University of East Anglia

• Duration of Study in the UK

  3 years, 4 months, 16 days

• Research summary

  We will be examining urine samples for prostate cancer markers to predict whether a man has an aggressive prostate cancer or not. Samples will be collected from men in the USA and South Africa. The samples will be sent to us at the University of East Anglia for analysis.

• REC name

  South Central - Hampshire A Research Ethics Committee

• REC reference

  25/SC/0233

• Date of REC Opinion

  14 Jul 2025

• REC opinion

  Further Information Favourable Opinion